Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony
This study has been terminated.
( Low efficacy rates )
Study NCT01380301   Information provided by Foundation Fader

First Received on January 28, 2009.   Last Updated on June 22, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cutaneous Leishmaniasis
Additional conditions recognized in this trial
Leishmaniasis
Leishmaniasis, Cutaneous
More general conditions related to this trial
Euglenozoa Infections
Parasitic Diseases
Protozoan Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
Miltefosine and antimony
Miltefosine alone
Additional drug interventions recognized in this trial
Miltefosine
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Foundation Fader
AB Foundation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services